Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
9.50
-0.03 (-0.31%)
At close: Sep 11, 2026, 4:00 PM EDT
9.71
+0.21 (2.21%)
After-hours: Sep 11, 2026, 4:29 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $102.26 million as of September 11, 2026. Its market cap has increased by 38.84% in one year.
Market Cap
102.26M
Enterprise Value
-3.07M
1-Year Change
38.84%
Ranking
Category
Stock Price
$9.50
ChartMarket Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $102.26M, a decrease of -66.10%. That is a compound annual growth rate of -16.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 102.26M | 20.17% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 111.70M |
| Genelux | 111.13M |
| Aardvark Therapeutics | 109.64M |
| PMV Pharmaceuticals | 108.74M |
| Seer, Inc. | 106.87M |
| Coya Therapeutics | 106.03M |
| PolyPid | 104.81M |
| Fractyl Health | 102.37M |